Skip to main content

Table 3 Prediction models for the undifferentiated pleomorphic sarcoma cohort based on each type of splicing event

From: Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas

Risk score Model HR (95% CI) p-value ROC
Risk score (AD) ATP6AP1_90605_AD * 2.273 + DNAJB12_12092_AD * (− 0.121) + KLC1_29490_AD * (− 0.111) + LRIF1_4128_AD * (− 0.28) + RAI14_71719_AD * (− 5.893) 5.742 (2.015–16.36) 0.0011 0.756
Risk score (AP) 6-Sep_89962_AP * (− 0.393) + ALKBH7_47027_AP * (− 0.255) + KIAA1217_10996_AP * 0.716 + UBR4_876_AP * 0.071 8.892 (2.951–26.80) 0.0001 0.931
Risk score (AT) GNPDA1_73859_AT * (− 8.763) + IL18BP_17471_AT * 0.073 + KLHL26_48496_AT * 0.155 5.391 (1.877–15.49) 0.0018 0.843
Risk score (ES) PARD3B_57099_ES * (− 0.448) + PDDC1_13757_ES * (− 1.314) + TMUB2_41797_ES * (− 0.193) 4.690 (1.674–13.14) 0.0033 0.669
Risk score (ME) FYN_77273_ME * 0.128 + NDUFAF6_84594_ME * (− 0.059) 3.170 (1.143–8.788) 0.027 0.70
Risk score (RI) ANKRD28_63628_RI * (− 0.917) + RAB43_66696_RI * (− 0.067) + ZNF773_52280_RI * 0.348 4.966 (1.739–14.18) 0.0028 0.81
Risk score (merged) ATP6AP1_90605_AD * 16.015 + UBR4_876_AP * (− 0.25) + GNPDA1_73859_AT * (− 120.044) + KLHL26_48496_AT * 2.08 3.780 (1.324–10.79) 0.013 0.869
\